Jalal Farhang Vargha, DO
Cardiovascular Disease (Cardiology) · Oakland
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 25
Offices
25 locations · Sutter Bay Medical Foundation · Alegent Creighton Clinic · Franciscan Care Services Inc
Looking this up.
Hospitals listed: Chi Health Creighton University Medical Center - B · Chi Health Immanuel · Chi Health Lakeside · Franciscan Healthcare · Memorial Community Hospital & Health System. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Vargha’s office to ask if they take your plan before you enroll.
Hospitals they work in
5 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Chi Health Bergan MercyOmaha, NEAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 3 of 5 · 62% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.143, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.208, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0, Oct 2024 – Sep 2025
- Chi Health ImmanuelOmaha, NEAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 3 of 5 · 63% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.108, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Chi Health LakesideOmaha, NEAcute Care Hospital · Voluntary non-profit - Church · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 3 of 5 · 63% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.253, Oct 2024 – Sep 2025
- Memorial Community Hospital & Health SystemBlair, NECritical Access Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 3 of 5 · 72% would definitely recommend itNo overall ratingNo measure marked better or worse than the national rate
- St Francis Memorial HospitalWest Point, NECritical Access Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendly84% would definitely recommend itOverall rating: 2 of 5 starsNo measure marked better or worse than the national rate
See every measure and the patient survey for Chi Health Bergan Mercy
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 3 better, 3 the same, 0 worse of 6 measures. Readmissions: 1 better, 8 the same, 1 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.143 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.208 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.94 (0.03 to 1.86) · 1,299 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.99 (0.72 to 1.26) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 196.99 (153.73 to 240.24) · 131 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 3.4 · 76 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.4 · 51 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.4 · 136 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.6 · 311 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.5 · 196 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.8 · 290 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.5 · 2,703 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.35 (0.15 to 0.55) · 5,971 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.06 to 0.44) · 6,065 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.23 (2.33 to 6.13) · 1,826 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.38 (0.97 to 3.79) · 730 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.88 (0.51 to 3.25) · 1,773 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.56 (5.68 to 15.44) · 775 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (2.04 to 8.25) · 746 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.56 (0.12 to 3) · 298 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.86) · 5,151 cases | No different | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.463 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.007 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 232 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.2 · 508 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -16.8 · 196 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 9.6 · 384 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.5 · 201 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.6 · 320 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5 (3.3 to 7.4) · 96 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.7 (7.8 to 14.4) · 96 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 10.4 · 69 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 98 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.2 (8.4 to 15) · 616 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.3) · 403 cases | No different | Jan 2024 – Dec 2024 |
What patients said (589 patients answered, 18% of those asked)
| Cleanliness | 2 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 2 |
| Quietness | 3 |
| Recommend hospital | 3 |
| Room was "always" clean | 63% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 67% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 66% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 62% |
| Staff "always" explained possible side effects | 41% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
See every measure and the patient survey for Chi Health Immanuel
Behind the star rating — Deaths: 0 better, 6 the same, 0 worse of 6 measures. Safety: 3 better, 3 the same, 0 worse of 6 measures. Readmissions: 0 better, 5 the same, 1 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.108 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.18 to 2.25) · 506 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.83 (0.44 to 1.23) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 9.2 · 25 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.9 · 51 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.7 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16 · 110 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 13.6 · 217 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.4 · 1,444 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.25 (0.02 to 0.47) · 2,527 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.29 (0.08 to 0.5) · 2,519 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.66 (1.29 to 6.03) · 420 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.64 (0 to 3.35) · 126 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.15 (0.48 to 3.81) · 416 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.5 (0 to 16.61) · 132 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.75 (0.61 to 8.88) · 118 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.73 (0.21 to 3.24) · 119 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.24 (0 to 1.08) · 2,120 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.422 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.315 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 2.074 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.5 · 72 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 23.4 · 299 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 148 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 40.3 · 113 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.3 · 217 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 86 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.3 (9 to 16.5) · 264 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 186 cases | No different | Jan 2024 – Dec 2024 |
What patients said (735 patients answered, 16% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 3 |
| Room was "always" clean | 67% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 65% |
| Staff "always" explained new medications | 69% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 56% |
| "YES", patients would definitely recommend the hospital | 63% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for Chi Health Lakeside
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 1 better, 7 the same, 0 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.253 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.9 (0 to 1.91) · 724 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.85 (0.48 to 1.23) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 159.97 (105.08 to 214.87) · 40 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.7 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 167 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 13.3 · 266 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.4 · 166 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.3 · 166 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 1,821 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.17 (0 to 0.39) · 3,648 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.03 to 0.44) · 3,592 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.09 (1.83 to 6.36) · 703 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.59 (0 to 3.28) · 181 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.1 (0.46 to 3.75) · 649 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.32 (0 to 16.67) · 202 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (1.22 to 9.18) · 178 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.67 (0.18 to 3.16) · 146 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 1.04) · 2,960 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 61 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.321 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.138 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.4 · 145 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.7 · 359 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -18.2 · 131 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -6.6 · 286 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -11 · 159 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.1 · 223 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.2 · 66 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.7 · 83 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.9 (9 to 15.7) · 769 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 500 cases | No different | Jan 2024 – Dec 2024 |
What patients said (522 patients answered, 21% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 4 |
| Recommend hospital | 3 |
| Room was "always" clean | 67% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 66% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 62% |
| "YES", patients would definitely recommend the hospital | 63% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Memorial Community Hospital & Health System
Behind the star rating — Deaths: 0 better, 1 the same, 0 worse of 1 measures. Readmissions: 0 better, 4 the same, 0 worse of 4 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate for pneumonia patientsComplications and deaths | 16.5 · 25 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.2 · 60 cases | None | Jul 2024 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.2 (4 to 9.7) · 25 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.8 (7.5 to 15.3) · 25 cases | No different | Jan 2024 – Dec 2024 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (9.4 to 17.1) · 187 cases | No different | Jan 2022 – Dec 2024 |
What patients said (115 patients answered, 24% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 5 |
| Recommend hospital | 4 |
| Room was "always" clean | 80% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 68% |
| Doctors "always" listened carefully | 71% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 66% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 72% |
| "YES", patients would definitely recommend the hospital | 72% |
| Staff "always" explained possible side effects | 52% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for St Francis Memorial Hospital
Behind the star rating — Deaths: 0 better, 4 the same, 0 worse of 4 measures. Safety: 0 better, 1 the same, 0 worse of 1 measures. Readmissions: 0 better, 3 the same, 0 worse of 3 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate for heart failure patientsComplications and deaths | 16.1 · 51 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 19.9 · 78 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 5.7 · 141 cases | None | Jul 2024 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.4 · 34 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 1 · 48 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -12 · 75 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.2 · 53 cases | None | Jul 2023 – Jun 2025 |
| Room was "always" clean | 87% |
| Nurses "always" communicated well | 90% |
| Doctors "always" communicated well | 89% |
| Staff "always" explained | 69% |
| Yes, staff "did" give patients this information | 94% |
| Yes, staff "did" give patients information about help after discharge | 93% |
| Doctors "always" explained things so they could understand | 81% |
| Doctors "always" listened carefully | 91% |
| Doctors "always" treated them with courtesy and respect | 96% |
| Patients who gave a rating of "9" or "10" (high) | 86% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 82% |
| Nurses "always" listened carefully | 90% |
| Nurses "always" treated them with courtesy and respect | 96% |
| "Always" quiet at night | 71% |
| "YES", patients would definitely recommend the hospital | 84% |
| Staff "always" explained possible side effects | 62% |
| Yes, staff "did" give patients information about possible symptoms | 94% |
Original Medicare doctor bills
$102,393
Medicare paid this office $102,393 for 1,504 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 465 | $22,014 | $47 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 141 | $21,054 | $86 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 133 | $17,193 | $125 |
| Return visit (30+ min) | 121 | $10,967 | $79 |
| New patient visit (45+ min) | 40 | $4,586 | $115 |
See all 25 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 465 | $22,014 | $47 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 141 | $21,054 | $86 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 133 | $17,193 | $125 |
| Return visit (30+ min) | 121 | $10,967 | $79 |
| New patient visit (45+ min) | 40 | $4,586 | $115 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 579 | $4,165 | $6 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 28 | $2,844 | $95 |
| Ultrasound of heart with probe in esophagus, with report | 34 | $2,729 | $78 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 49 | $2,626 | $54 |
| Ultrasound of heart, follow-up | 110 | $2,023 | $18 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 20 | $1,553 | $58 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 29 | $1,281 | $44 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 15 | $1,127 | $75 |
| Mri scan of heart before and after contrast | 12 | $990 | $82 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 97 | $947 | $9 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 47 | $719 | $15 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 58 | $587 | $10 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 48 | $545 | $11 |
| Anticoagulant management of patient taking warfarin | 32 | $208 | $7 |
| Blood test, clotting time | 22 | $167 | $4 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 12 | $149 | $12 |
| Heart muscle strain imaging | 17 | $142 | $8 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 26 | $119 | $5 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 45 | $99 | $2 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 15 | $78 | $5 |
Who their Medicare patients are
1,504 Original Medicare patients in 2024. Average age 76 · Under 65 6% · 85 and older 19% · Women 51% · Also on Medicaid 14% · Health risk score 1.83. Above the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Coronary heart disease 48% · Chronic kidney disease 46% · Heart failure 44% · Atrial fibrillation 43% · Diabetes 40% · Depression 34% · COPD 30% · Stroke 23% · Cancer 20% · Dementia 15%.
The office billed $422,809, Medicare allowed $134,894 and paid $102,393; for 2,620 services of 43 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,504 | 2,620 | 76 | 1.83 | $422,809 | $102,393 |
| 2023 | 1,461 | 2,578 | 75 | 1.88 | $438,319 | $108,831 |
| 2022 | 1,275 | 2,075 | 76 | 1.66 | $234,463 | $77,195 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 25 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 120 | $20,744 | $87 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 142 | $18,241 | $128 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 344 | $17,292 | $50 |
| Return visit (30+ min) | 137 | $15,723 | $84 |
| Ultrasound of heart with probe in esophagus, with report | 66 | $5,494 | $80 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 94 | $5,178 | $55 |
| New patient visit (45+ min) | 41 | $4,925 | $120 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 509 | $3,484 | $6 |
| External shock to heart to regulate heart beat | 30 | $2,193 | $73 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 36 | $2,160 | $60 |
| Ultrasound of heart, follow-up | 91 | $1,729 | $18 |
| Mri scan of heart before and after contrast | 12 | $1,106 | $92 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 101 | $1,058 | $10 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 89 | $912 | $10 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 57 | $889 | $16 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 16 | $825 | $52 |
| Ultrasound of heart blood flow, valves and chambers | 36 | $493 | $13 |
| Anticoagulant management of patient taking warfarin | 49 | $348 | $7 |
| 3d radiographic procedure | 40 | $290 | $7 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 13 | $252 | $19 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 84 | $199 | $2 |
| Insertion of needle into vein for collection of blood sample | 12 | $103 | $7 |
| Blood test, clotting time | 14 | $101 | $4 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 15 | $86 | $6 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 16 | $84 | $5 |
2022: 25 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 289 | $15,268 | $53 |
| Return visit (30+ min) | 101 | $12,204 | $92 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 63 | $8,118 | $75 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 52 | $7,761 | $146 |
| New patient visit (45+ min) | 39 | $4,574 | $117 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 500 | $3,768 | $6 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 47 | $3,513 | $52 |
| Ultrasound of heart with probe in esophagus, with report | 36 | $2,964 | $82 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 42 | $2,448 | $58 |
| External shock to heart to regulate heart beat | 24 | $1,902 | $79 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 19 | $1,900 | $100 |
| Ultrasound of heart, follow-up | 68 | $1,306 | $19 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 19 | $1,147 | $60 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 20 | $1,069 | $53 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 84 | $859 | $10 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 35 | $556 | $16 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 47 | $503 | $11 |
| Anticoagulant management of patient taking warfarin | 61 | $500 | $8 |
| Ultrasound of heart blood flow, valves and chambers | 29 | $399 | $14 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 74 | $183 | $2 |
| Blood test, clotting time | 19 | $161 | $4 |
| 3d radiographic procedure | 21 | $153 | $7 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 11 | $142 | $13 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 13 | $136 | $10 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 14 | $76 | $5 |
Medicaid work
$43,341 in 2024
Medicaid paid $43,341 for 1,157 billed services this clinician did in 2024, up to 91 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 379 | $27,259 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 687 | $10,828 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 34 | $2,527 |
| 1ST HOSP IP/OBS HIGH 75 | 18 | $1,611 |
| Return visit (30+ min) | 12 | $678 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 14 | $413 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 13 | $26 |
| 2024 | 1,157 | 7 | 91 | $43,341 |
| 2023 | 1,033 | 4 | 108 | $28,336 |
| 2022 | 735 | 3 | 68 | $16,643 |
See the largest Medicaid services in earlier years
2023
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 224 | $14,251 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 700 | $10,467 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 95 | $2,414 |
| 1ST HOSP IP/OBS HIGH 75 | 14 | $1,204 |
2022
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 116 | $7,804 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 577 | $7,517 |
| Return visit (30+ min) | 42 | $1,322 |
Drugs they prescribed that Part D paid
$251,946
Pharmacies billed $251,946 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,242) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
958 generic and 284 brand-name prescriptions · $251,946 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 156 | $150,661 | $966 |
| Xarelto | 22 | $25,097 | $1,141 |
| Entresto | 21 | $22,236 | $1,059 |
| Brilinta | 14 | $14,775 | $1,055 |
| Repatha Sureclick | 20 | $12,275 | $614 |
See all 25 drugs
| Eliquis | 156 | $150,661 | $966 |
| Xarelto | 22 | $25,097 | $1,141 |
| Entresto | 21 | $22,236 | $1,059 |
| Brilinta | 14 | $14,775 | $1,055 |
| Repatha Sureclick | 20 | $12,275 | $614 |
| Jardiance | 13 | $8,881 | $683 |
| Metoprolol | 162 | $1,968 | $12 |
| Atorvastatin | 131 | $1,310 | $10 |
| Diltiazem 24hr Er (Cd) | 42 | $1,125 | $27 |
| Amiodarone | 28 | $1,067 | $38 |
| Amlodipine Besylate | 76 | $521 | $7 |
| Potassium Chloride | 37 | $494 | $13 |
| Ezetimibe | 18 | $435 | $24 |
| Clopidogrel | 48 | $419 | $9 |
| Furosemide | 82 | $360 | $4 |
| Spironolactone | 26 | $353 | $14 |
| Carvedilol | 35 | $341 | $10 |
| Rosuvastatin | 20 | $278 | $14 |
| Metoprolol | 56 | $230 | $4 |
| Lisinopril | 44 | $172 | $4 |
| Isosorbide Mononitrate Er | 25 | $163 | $7 |
| Flecainide Acetate | 13 | $158 | $12 |
| Warfarin | 19 | $136 | $7 |
| Nitroglycerin | 15 | $122 | $8 |
| Digoxin | 11 | $68 | $6 |
Year by year
| 2024 | 1,242 | 199 | 0% (0) | 23% | $251,946 |
| 2023 | 853 | 169 | 0% (0) | 24% | $184,668 |
| 2022 | 254 | 75 | 0% (0) | 27% | $49,761 |
| 2021 | 14 | None | 0% (0) | None | $1,780 |
| 2020 | 192 | 31 | 0% (0) | 20% | $23,202 |
| 2019 | 236 | 47 | 0% (0) | 28% | $29,532 |
| 2018 | 159 | 38 | 0% (0) | 21% | $10,181 |
| 2017 | 131 | 36 | None | 18% | $11,992 |
| 2016 | 120 | 29 | None | 17% | $6,323 |
| 2015 | 92 | 25 | None | 14% | $3,896 |
| 2014 | 39 | None | 0% (0) | None | $1,540 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 19 drugs
| Eliquis | 110 | $118,016 | $1,073 |
| Xarelto | 26 | $19,162 | $737 |
| Metoprolol | 96 | $2,116 | $22 |
| Amiodarone | 30 | $1,291 | $43 |
| Atorvastatin | 66 | $1,176 | $18 |
| Diltiazem 24hr Er (Cd) | 30 | $1,112 | $37 |
| Tiadylt Er | 16 | $877 | $55 |
| Potassium Chloride | 30 | $730 | $24 |
| Clopidogrel | 39 | $704 | $18 |
| Amlodipine Besylate | 52 | $500 | $10 |
| Losartan | 20 | $420 | $21 |
| Carvedilol | 26 | $371 | $14 |
| Furosemide | 71 | $317 | $4 |
| Nitroglycerin | 21 | $297 | $14 |
| Rosuvastatin | 14 | $270 | $19 |
| Isosorbide Mononitrate Er | 24 | $258 | $11 |
| Spironolactone | 13 | $193 | $15 |
| Metoprolol | 29 | $182 | $6 |
| Lisinopril | 20 | $153 | $8 |
2022: 8 drugs
| Eliquis | 44 | $34,303 | $780 |
| Atorvastatin | 20 | $545 | $27 |
| Nitroglycerin | 16 | $402 | $25 |
| Clopidogrel | 20 | $349 | $17 |
| Metoprolol | 13 | $342 | $26 |
| Potassium Chloride | 16 | $279 | $17 |
| Furosemide | 21 | $115 | $5 |
| Metoprolol | 15 | $84 | $6 |
2020: 6 drugs
| Xarelto | 24 | $10,886 | $454 |
| Atorvastatin | 40 | $357 | $9 |
| Flecainide Acetate | 11 | $223 | $20 |
| Carvedilol | 11 | $158 | $14 |
| Metoprolol | 23 | $87 | $4 |
| Spironolactone | 13 | $75 | $6 |
2019: 7 drugs
| Eliquis | 26 | $15,021 | $578 |
| Xarelto | 14 | $7,968 | $569 |
| Flecainide Acetate | 13 | $691 | $53 |
| Atorvastatin | 26 | $355 | $14 |
| Diltiazem 24hr Er | 11 | $214 | $19 |
| Sotalol | 12 | $113 | $9 |
| Clopidogrel | 19 | $111 | $6 |
2018: 5 drugs
| Eliquis | 12 | $5,087 | $424 |
| Cartia Xt | 19 | $414 | $22 |
| Atorvastatin | 18 | $260 | $14 |
| Flecainide Acetate | 11 | $167 | $15 |
| Metoprolol | 19 | $68 | $4 |
2017: 1 drug
| Lisinopril | 13 | $50 | $4 |
2016: 1 drug
| Losartan-Hydrochlorothiazide | 14 | $165 | $12 |
2015: 1 drug
| Atorvastatin | 11 | $79 | $7 |
Money from drug and device companies
$812 in 2025
| 2025 | 9 | 42 | None | $812 |
| 2024 | 9 | 55 | None | $1,214 |
| 2023 | 14 | 38 | None | $1,339 |
| 2022 | 7 | 11 | None | $574 |
| 2019 | 1 | 3 | None | $113 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Novartis Pharmaceuticals | Leqvio | $232 | 17 payments
|
| E.R. Squibb & Sons L.L.C. | Camzyos | $212 | 7 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $150 | 10 payments
|
| Heartflow | Ffrct | $86 | 1 payment
|
| Amgen | Repatha | $39 | 2 payments
|
| Medtronic | Euphora | $29 | 2 payments
|
See all 42 published payments
| GlaxoSmithKline | Meals · 2025-12-18 | Shingrix | $27 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-12-16 | Jardiance | $21 |
| Novartis Pharmaceuticals | Meals · 2025-11-18 | Leqvio | $14 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-11-10 | Jardiance | $16 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-10-14 | Jardiance | $22 |
| Novartis Pharmaceuticals | Meals · 2025-10-13 | Leqvio | $12 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-10-07 | Camzyos | $11 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-10-06 | Camzyos | $3 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-09-05 | Camzyos | $16 |
| Novartis Pharmaceuticals | Meals · 2025-09-03 | Leqvio | $19 |
| Novartis Pharmaceuticals | Meals · 2025-08-07 | Leqvio | $19 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-08-06 | Jardiance | $16 |
| Novartis Pharmaceuticals | Meals · 2025-07-31 | Leqvio | $13 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-07-23 | None | $130 |
| Amgen | Meals · 2025-07-17 | Repatha | $19 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-07-11 | Eliquis | $23 |
| Novartis Pharmaceuticals | Meals · 2025-07-09 | Leqvio | $16 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-06-12 | Jardiance | $10 |
| Amgen | Meals · 2025-06-12 | None | $19 |
| Novartis Pharmaceuticals | Meals · 2025-06-11 | Leqvio | $12 |
| Scpharmaceuticals | Meals · 2025-06-11 | Furoscix | $23 |
| Pfizer | Meals · 2025-06-05 | Vyndaqel | $15 |
| Novartis Pharmaceuticals | Meals · 2025-05-01 | Leqvio | $19 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-05-01 | Jardiance | $12 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-05-01 | Jardiance | $5 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-04-22 | Eliquis | $15 |
| Novartis Pharmaceuticals | Meals · 2025-04-22 | Leqvio | $12 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-04-16 | Jardiance | $16 |
| Novartis Pharmaceuticals | Meals · 2025-04-15 | Leqvio | $14 |
| Novartis Pharmaceuticals | Meals · 2025-04-07 | Leqvio | $13 |
| Novartis Pharmaceuticals | Meals · 2025-04-02 | Leqvio | $15 |
| Medtronic | Meals · 2025-03-20 | Complete Se Vascular | $14 |
| Novartis Pharmaceuticals | Meals · 2025-03-06 | Leqvio | $12 |
| Novartis Pharmaceuticals | Meals · 2025-02-25 | Leqvio | $11 |
| Novartis Pharmaceuticals | Meals · 2025-02-14 | Leqvio | $11 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-02-14 | Jardiance | $18 |
| Medtronic | Meals · 2025-01-16 | Euphora | $15 |
| Heartflow | Meals · 2025-01-16 | Ffrct | $86 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-01-15 | Camzyos | $15 |
| Novartis Pharmaceuticals | Meals · 2025-01-07 | Leqvio | $13 |
| Novartis Pharmaceuticals | Meals · 2025-01-03 | Entresto | $7 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-01-03 | Jardiance | $13 |
See earlier years (2024, 2023, 2022, 2019)
2024: $1,214
| Medtronic | Linq II | $320 | 6 payments
|
| Pfizer | Eliquis | $218 | 13 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $209 | 13 payments
|
| Novartis Pharmaceuticals | Leqvio | $183 | 14 payments
|
| Edwards Lifesciences | Sapien 3 Ultra Resilia | $153 | 1 payment
|
| Merck Sharp & Dohme | Verquvo | $51 | 3 payments
|
| Lexicon Pharmaceuticals | None | $50 | 3 payments
|
| E.R. Squibb & Sons L.L.C. | Camzyos | $17 | 1 payment
|
| Amgen | Repatha | $14 | 1 payment
|
2023: $1,339
| E.R. Squibb & Sons L.L.C. | Camzyos | $263 | 4 payments
|
| Abbott Laboratories | Mitraclip | $212 | 2 payments
|
| Amgen | Repatha | $197 | 10 payments
|
| Edwards Lifesciences | Pascal | $179 | 3 payments
|
| Scpharmaceuticals | Furoscix | $99 | 1 payment
|
| Boston Scientific | Watchman Access System | $96 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $83 | 5 payments
|
| Lexicon Pharmaceuticals | Inpefa | $59 | 3 payments
|
| Merck Sharp & Dohme | Verquvo | $43 | 3 payments
|
| Novartis Pharmaceuticals | Leqvio | $31 | 2 payments
|
| Pfizer | Eliquis | $27 | 1 payment
|
| Philips Electronics North America | (5044) Mcot | $18 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $16 | 1 payment
|
| Actelion Pharmaceuticals US | Opsumit | $14 | 1 payment
|
2022: $574
| Janssen Pharmaceuticals | Xarelto | $239 | 2 payments
|
| Boston Scientific | Watchman Access System | $230 | 2 payments
|
| Amgen | Repatha | $46 | 3 payments
|
| Terumo Medical | Glidewire | $18 | 1 payment
|
| Actelion Pharmaceuticals US | Opsumit | $15 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $14 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $12 | 1 payment
|
2019: $113
| Medtronic Vascular | Azure | $113 | 3 payments
|
Professional record
- NPI
- 1639599467
- Licence
- NE 2477
- Group
- Sutter Bay Medical Foundation · Alegent Creighton Clinic · Franciscan Care Services Inc
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Cardiology (207RC0000X); Student in a training program (390200000X)
- Mailing address
- Po Box 276950, Sacramento, CA, 95827
- NPI first listed
- 2014-04-19
- NPI last updated
- 2026-05-26
- NPI record certified
- 2026-05-26
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 350 30th St Ste 411, Oakland, CA, 94609